Big Move For Cassava Sciences, Inc.

Cassava Sciences, Inc. (SAVA:NASDAQ) rocketted at $3.42, representing a gain of 67.6%. The stock appeared on our News Catalysts scanner on Wed 03 Jun 20 at 10:04 AM in the 'BIOTECH' category. From Tue 19 May 20, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Fri 03 Jan 20 at $10.95 with a volume of 36M+, and its share price has been moving sideways in recent weeks.

About Cassava Sciences, Inc. (SAVA:NASDAQ)

Pain Therapeutics Inc is a biopharmaceutical company. It develops proprietary drugs that offer improvements to patients and healthcare professionals. The company generally focuses on the drug development efforts on disorders of the nervous system, such as chronic pain. Pain Therapeutics operates in the single operating segment. Pain Therapeutics's drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The company's other product includes FENROCK. REMOXY is a painkiller with a formulation designed to reduce potential risks of unintended use.